The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia
Open accessAbstract
Aims/hypothesis Under normal physiological conditions, glucagon signalling is important in glucose homeostasis. Hyperglucagonaemia or altered insulin:glucagon ratio plays a role in maintaining hyperglycaemia in subjects with type 2 diabetes. It has been reported that glucagon receptor knockout (Gcgr (-/-)) mice develop normally and have lower plasma glucose on a normal diet. The goal of the current research was to further investigate the role of glucagon signalling in metabolic control and glucose homeostasis.Methods Gcgr (-/-) mice were challenged with a high-fat diet (HFD) and with streptozotocin, which induces beta cell damage. They were then analysed for whole-body and serum metabolic phenotypes as well as pancreatic islet morphology.Results In comparison with wild-type mice, Gcgr (-/-) mice exhibited decreased body weight and food intake, reduced plasma glucose levels, and improved oral and intraperitoneal glucose tolerance. Elevated glucagon-like peptide-1 levels and reduced gastric emptying were also observed in Gcgr (-/-) mice, which also had reduced HFD-induced hyperinsulinaemia and hyperleptinaemia, and were resistant to the development of hepatic steatosis. In addition, Gcgr (-/-) mice were resistant to STZ-induced hyperglycaemia and pancreatic beta cell destruction.Conclusions/interpretation This study demonstrates that blocking glucagon signalling by targeted Gcgr gene deletion leads to an improvement in metabolic control in this mouse model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While lack of GCGR signaling can normalize glycemia under insulin-deficient conditions15,16, this effect is contingent on the presence of residual insulin17.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [15]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905
Self-citationGelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
Self-citationMinireview: The Glucagon-Like Peptides
Drucker, D. J. (2001) · Endocrinology · doi:10.1210/endo.142.2.7983 · Cited by 419
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
Shah, P., Vella, A., Basu, A., Basu, R., Schwenk, W. F., & Rizza, R. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6993 · Cited by 368
Glucagon physiology and pathophysiology in the light of new advances
Unger, R. H. (1985) · Diabetologia · doi:10.1007/bf00281991 · Cited by 361
Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
Conarello, S., Li, Z., Ronan, J., Roy, R. S., Zhu, L., Jiang, G., Liu, F., Woods, J. W., Zycband, E., Moller, D. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631828100 · Cited by 348
Self-citationPospisilik, J. A., Martin, J., Doty, T., Ehses, J. A., Pamir, N., Lynn, F. C., Piteau, S., Demuth, H.-U., McIntosh, C. H. S., & Pederson, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.741 · Cited by 332
Sloop, K. W., Cao, J. X. C., Siesky, A. M., Zhang, H. Y., Bodenmiller, D. M., Cox, A. L., Jacobs, S. J., Moyers, J. S., Owens, R. A., Showalter, A. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20911 · Cited by 219
Petersen, K. F., & Sullivan, J. T. (2001) · Diabetologia · doi:10.1007/s001250100006 · Cited by 212
Flagged first, then by citations
Cited by
Sorted by citations
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130024 · Cited by 2,401
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, S., Nawroth, P. P., Herzig, S., & Üstünel, B. E. (2021) · Advanced Science · doi:10.1002/advs.202100275 · Cited by 582
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Hormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429
The metabolic actions of glucagon revisited
Habegger, K. M., Heppner, K. M., Geary, N., Bartness, T. J., DiMarchi, R., & Tschöp, M. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.187 · Cited by 406
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice
Lee, Y., Wang, M.-Y., Du, X. Q., Charron, M. J., & Unger, R. H. (2011) · Diabetes · doi:10.2337/db10-0426 · Cited by 327
Self-citationThe Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
Longuet, C., Sinclair, E. M., Maida, A., Baggio, L. L., Maziarz, M., Charron, M. J., & Drucker, D. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.008 · Cited by 272
Self-citationThe role of dysregulated glucagon secretion in type 2 diabetes
D'Alessio, D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01449.x · Cited by 238
A glucagon-like endocrine pathway in Drosophila modulates both lipid and carbohydrate homeostasis
Bharucha, K. N., Tarr, P., & Zipursky, S. L. (2008) · Journal of Experimental Biology · doi:10.1242/jeb.016451 · Cited by 239
OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
Li, E., Shan, H., Chen, L., Long, A., Zhang, Y., Liu, Y., Jia, L., Wei, F., Han, J., Li, T., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.022 · Cited by 223
Glucagon Receptor Signaling and Lipid Metabolism
Galsgaard, K. D., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00413 · Cited by 218
KAZDA, C. M., Ding, Y., Kelly, R. P., Garhyan, P., Shi, C., Lim, C. N., Fu, H., Watson, D. E., Lewin, A. J., Landschulz, W. H., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1643 · Cited by 214
Brereton, M. F., Vergari, E., Zhang, Q., & Clark, A. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415583535 · Cited by 206
Glucagon Receptor Signaling and Glucagon Resistance
Janah, L., Kjeldsen, S. A. S., Galsgaard, K. D., Winther‐Sørensen, M., Stojanovska, E., Pedersen, J., Knop, F. K., Holst, J. J., & Albrechtsen, N. J. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133314 · Cited by 221
Pathophysiology of Non Alcoholic Fatty Liver Disease
Petta, S., Gastaldelli, A., Rebelos, E., Bugianesi, E., Messa, P., Miele, L., Svegliati‐Baroni, G., Valenti, L. V. C., & Bonino, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122082 · Cited by 182
Glucagon is the key factor in the development of diabetes
Lee, Y. H., Wang, M.-Y., Yu, X., & Unger, R. H. (2016) · Diabetologia · doi:10.1007/s00125-016-3965-9 · Cited by 167
The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes
Hædersdal, S., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.12.003 · Cited by 162
The Liver–α-Cell Axis and Type 2 Diabetes
Albrechtsen, N. J. W., Pedersen, J., Galsgaard, K. D., Winther‐Sørensen, M., Suppli, M. P., Janah, L., Gromada, J., Vilstrup, H., Knop, F. K., & Holst, J. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00251 · Cited by 154
Insulin as a physiological modulator of glucagon secretion
Bansal, P., & Wang, Q. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90295.2008 · Cited by 152
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 144
Minireview: Glucagon in Stress and Energy Homeostasis
Jones, B. J., Tan, T., & Bloom, S. R. (2012) · Endocrinology · doi:10.1210/en.2011-1979 · Cited by 144
Dissociating fatty liver and diabetes
Sun, Z., & Lazar, M. A. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.005 · Cited by 143
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes
Ali, S., & Drucker, D. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90887.2008 · Cited by 124
Transforming obesity: The advancement of multi-receptor drugs
Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024) · Cell · doi:10.1016/j.cell.2024.06.003 · Cited by 126
100 years of glucagon and 100 more
Wewer Albrechtsen, N. J., Holst, J. J., Cherrington, A. D., Finan, B., Gluud, L. L., Dean, E. D., Campbell, J. E., Bloom, S. R., Tan, T. M.-M., Knop, F. K., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05947-y · Cited by 117
Galsgaard, K. D., Winther‐Sørensen, M., Ørskov, C., Kissow, H., Poulsen, S. S., Vilstrup, H., Prehn, C. P., Adamski, J., Jepsen, S. L., Hartmann, B., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00198.2017 · Cited by 117
Self-citationTraub, S., Meier, D. T., Schulze, F., Dror, E., Nordmann, T. M., Goetz, N., Koch, N., Dalmas, É., Stawiski, M., Makshana, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.005 · Cited by 115
Kelly, R. P., Garhyan, P., Raddad, E., Fu, H., Lim, C. N., Prince, M. J., Pinaire, J. A., Loh, M. T., & Deeg, M. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12446 · Cited by 110
The past, present, and future physiology and pharmacology of glucagon
Capozzi, M. E., D’Alessio, D. A., & Campbell, J. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.001 · Cited by 114
Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis
Ali, S., Lamont, B. J., Charron, M. J., & Drucker, D. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43615 · Cited by 111
Self-citationGu, W., Yan, H., Winters, K. A., Komorowski, R., Vonderfecht, S. L., Atangan, L. I., Sivits, G. N., Hill, D., Yang, J., Bi, V., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157685 · Cited by 105
Kim, T., Nason, S., Holleman, C., Pepin, M., Wilson, L., Berryhill, T. F., Wende, A. R., Steele, C., Young, M. E., Barnes, S., et al. (2018) · Diabetes · doi:10.2337/db17-1502 · Cited by 97
Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells
Lee, Y., Berglund, E. D., Yu, X., Wang, M.-Y., Evans, M. R., Scherer, P. E., Holland, W. L., Charron, M. J., Roth, M. G., & Unger, R. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409638111 · Cited by 97
Self-citationA Primary Role for α-Cells as Amino Acid Sensors
Dean, E. D. (2019) · Diabetes · doi:10.2337/dbi19-0021 · Cited by 97
Glucagon Deficiency Reduces Hepatic Glucose Production and Improves Glucose Tolerance In Adult Mice
Hancock, A. S., Du, A., Liu, J., Miller, M. F., & May, C. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0120 · Cited by 91
Glucagon contributes to liver zonation
Cheng, X., Kim, S. Y., Okamoto, H., Xin, Y., Yancopoulos, G. D., Murphy, A. J., & Gromada, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721403115 · Cited by 90
Glucagon Control on Food Intake and Energy Balance
Al–Massadi, O., Fernø, J., Diéguez, C., Nogueiras, R., & Quiñones, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163905 · Cited by 94
Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes
Scheen, A. J., Paquot, N., & Lefèbvre, P. J. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1395020 · Cited by 88
Yang, J., MacDougall, M. L., McDowell, M. T., Xi, L., Wei, R., Zavadoski, W. J., Molloy, M. P., Baker, J. D., Kühn, M., Cabrera, O., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-281 · Cited by 82
α-cell role in β-cell generation and regeneration
Habener, J. F., & Stanojevic, V. (2012) · Islets · doi:10.4161/isl.20500 · Cited by 80
Insulin and Glucagon Regulate Pancreatic α-Cell Proliferation
Liu, Z., Kim, W., Chen, Z., Shin, Y., Carlson, O. D., Fiori, J. L., Li, X., Napora, J. K., Short, R. G., Odetunde, J. O., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016096 · Cited by 81
Omar, B. A., Andersen, B., Hald, J., Raun, K., Nishimura, E., & Åhrén, B. (2013) · Diabetes · doi:10.2337/db13-0710 · Cited by 76
Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
Damond, N., Thorel, F., Moyers, J. S., Charron, M. J., Vuguin, P. M., Powers, A. C., & Herrera, P. L. (2016) · eLife · doi:10.7554/elife.13828 · Cited by 74
Self-citationSharma, A. X., Quittner-Strom, E. B., Lee, Y., Johnson, J. A., Martin, S. A., Yu, X., Li, J., Lu, J., Cai, Z. P., Chen, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.065 · Cited by 71
Pancreatic Neuroendocrine Tumors in Glucagon Receptor-Deficient Mice
Yu, R., Dhall, D., Nissen, N. N., Zhou, C., & Ren, S.-G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023397 · Cited by 71
Johswich, A., Longuet, C., Pawling, J., Rahman, A. M. A., Ryczko, M. C., Drucker, D. J., & Dennis, J. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563734 · Cited by 71
Watanabe, C., Seino, Y., Miyahira, H., Yamamoto, M., Fukami, A., Ozaki, N., Takagishi, Y., Sato, J., Fukuwatari, T., Shibata, K., et al. (2011) · Diabetes · doi:10.2337/db11-0739 · Cited by 70
Lack of glucagon receptor signaling and its implications beyond glucose homeostasis
Charron, M. J., & Vuguin, P. M. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0614 · Cited by 68
Self-citationUCP2 Regulates the Glucagon Response to Fasting and Starvation
Allister, E. M., Doucette, C. A., Prentice, K. J., Hardy, A. B., Sultan, S., Gaisano, H. Y., Kong, D., Gilon, P., Herrera, P. L., Lowell, B. B., et al. (2013) · Diabetes · doi:10.2337/db12-0981 · Cited by 69
Pancreatic α-cells – The unsung heroes in islet function
Wendt, A., & Eliasson, L. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.01.006 · Cited by 75
Pancreatic α-cell dysfunction in diabetes
Burcelin, R., Knauf, C., & Cani, P. D. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73395-0 · Cited by 71
Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
Holter, M. M., Saikia, M., & Cummings, B. P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934775 · Cited by 63
Mu, J., Jiang, G., Brady, E. J., Dallas-Yang, Q., Liu, F., Woods, J., Zycband, E., Wright, M., Li, Z., Lü, K., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2217-2 · Cited by 64
Self-citationJun, L. S., Millican, R. L., Hawkins, E. D., Konkol, D. L., Showalter, A. D., Christe, M. E., Michael, M. D., & Sloop, K. W. (2015) · Diabetes · doi:10.2337/db14-1052 · Cited by 60
Xiao, C., Pavlic, M., Szeto, L., Patterson, B. W., & Lewis, G. F. (2010) · Diabetes · doi:10.2337/db10-0763 · Cited by 61
Glucagon's Metabolic Action in Health and Disease
Zeigerer, A., Sekar, R., Kleinert, M., Nason, S. R., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200013 · Cited by 87
Hepatic glucagon action: beyond glucose mobilization
Kajani, S., Laker, R. C., Ratkova, E. L., Will, S., & Rhodes, C. J. (2024) · Physiological Reviews · doi:10.1152/physrev.00028.2023 · Cited by 65
Glucagon Receptor Signaling Is Essential for Control of Murine Hepatocyte Survival
Sinclair, E. M., Yusta, B., Streutker, C., Baggio, L. L., Koehler, J. A., Charron, M. J., & Drucker, D. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.075 · Cited by 58
Self-citationSinger, R. A., Arnes, L., Cui, Y., Wang, J., Gao, Y., Guney, M. A., Burnum-Johnson, K., Rabadán, R., Ansong, C. K., Orr, G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.013 · Cited by 58
Hypothalamic CaMKKβ mediates glucagon anorectic effect and its diet-induced resistance
Quiñones, M., Al-Massadi, O., Gallego, R., Fernø, J., Diéguez, C., López, M., & Nogueiras, R. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.09.014 · Cited by 60
Habener, J. F., & Stanojevic, V. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.10.009 · Cited by 57
Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes
Jia, Y., Liu, Y., Feng, L., Sun, S., & Sun, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.928016 · Cited by 63
Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes
Marroquí, L., Alonso‐Magdalena, P., Merino, B., Fuentes, E., Nadal, Á., & Quesada, I. (2014) · Nutrition Research Reviews · doi:10.1017/s0954422414000031 · Cited by 57
Problem or solution: The strange story of glucagon
Scott, R., & Bloom, S. R. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.013 · Cited by 60
Paracrine signaling in islet function and survival
Hartig, S. M., & Cox, A. R. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01887-x · Cited by 65
Zhang, X., Cui, T., He, J., Wang, H., Cai, R., Popovics, P., Vidaurre, I., Sha, W., Schmid, J., Ludwig, B., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518540112 · Cited by 52
Gáliková, M., Klepsatel, P., Xu, Y., & Kühnlein, R. P. (2016) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201600138 · Cited by 52
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis
Kim, K., Ryu, D., Dongiovanni, P., Özcan, L., Nayak, S., Ueberheide, B. M., Valenti, L. V. C., Auwerx, J. H., & Pajvani, U. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.039 · Cited by 52
Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Hu, C., Chen, Y., Yin, X., Xu, R., Yin, C., Wang, C., & Zhao, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02098-3 · Cited by 69
Ramakrishnan, S. K., Zhang, H., Takahashi, S., Centofanti, B., Periyasamy, S., Weisz, K. M., Chen, Z., Uhler, M. D., Rui, L., Gonzalez, F. J., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.004 · Cited by 50
Mu, J., Qureshi, S. A., Brady, E. J., Muise, E. S., Candelore, M. R., Jiang, G., Li, Z., Wu, M. S., Yang, X., Dallas-Yang, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049572 · Cited by 50
Self-citationEndosomal trafficking in metabolic homeostasis and diseases
Gilleron, J., & Zeigerer, A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00737-9 · Cited by 57
Determination of gastric emptying in nonobese diabetic mice
Choi, K. M., Zhu, J., Stoltz, G. J., Vernino, S. A., Camilleri, M., Szurszewski, J. H., Gibbons, S. J., & Farrugia, G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00317.2007 · Cited by 49
Wang, M.-Y., Zhang, Z., Zhao, S., Onodera, T., Sun, X.-N., Zhu, Q., Li, C., Li, N., Chen, S., Paredes, M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.024 · Cited by 52
Self-citationDusaulcy, R., Handgraaf, S., Skarupelova, S., Visentin, F., Vesin, C., Heddad-Masson, M., Reimann, F. M., Gribble, F. M., Philippé, J., & Gosmain, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1433 · Cited by 50
Vajda, E. G., Logan, D. K., Lasseter, K. C., Armas, D. R., Plotkin, D. J., Pipkin, J., Li, Y.-X., Zhou, R., Klein, D. J., Wei, X., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12752 · Cited by 47
Wang, M.-Y., Dean, E. D., Quittner-Strom, E. B., Zhu, Y., Chowdhury, K. H., Zhang, Z., Zhao, S., Li, N., Ye, R., Lee, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022142118 · Cited by 47
Novel insight into glucagon receptor action: lessons from knockout and transgenic mouse models
Vuguin, P. M., & Charron, M. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01447.x · Cited by 47
Self-citationGlucagon as a Critical Factor in the Pathology of Diabetes
Edgerton, D. S., & Cherrington, A. D. (2011) · Diabetes · doi:10.2337/db10-1594 · Cited by 47
The relationships between high-fat diet and metabolic syndrome: Potential mechanisms
Tang, C., Wang, Y., Xu, Z., Chen, D., Xu, J., Yang, D., Zhang, L., Liu, J., & Kan, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104261 · Cited by 49
Pedersen, J., Ugleholdt, R., Jørgensen, S. M., Windeløv, J. A., Grunddal, K. V., Schwartz, T. W., Füchtbauer, E., Poulsen, S. S., Holst, P. J., & Holst, J. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2011 · Cited by 43
Wei, R., Gu, L., Yang, J., Yang, K., Liu, J., Le, Y.-Y., Lang, S., Wang, H.-N., Thai, D., Yan, H., et al. (2019) · iScience · doi:10.1016/j.isci.2019.05.030 · Cited by 35
Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish
Li, M., Dean, E. D., Zhao, L., Nicholson, W. E., Powers, A. C., & Chen, W. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0284 · Cited by 43
KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state
Ogata, H., Seino, Y., Harada, N., Iida, A., Suzuki, K., Izumoto, T., Ishikawa, K., Uenishi, E., Ozaki, N., Hayashi, Y., et al. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0161 · Cited by 44
Glucagon and Cyclic AMP: Time to Turn the Page?
Rodgers, R. L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912802083540 · Cited by 42
Ande, S., Klarmann, K. D., Gavrilova, O., & Keller, J. R. (2011) · The FASEB Journal · doi:10.1096/fj.11-190892 · Cited by 42
Khatri, N., Sagar, A., Peddada, N., Choudhary, V., Chopra, B. S., Garg, V., Garg, R., & Ashish (2014) · Journal of Diabetes Research · doi:10.1155/2014/152075 · Cited by 37
Glucagon‐Like Peptide‐1: Actions and Influence on Pancreatic Hormone Function
Davis, E., & Sandoval, D. A. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190025 · Cited by 53
Merino, B., Alonso‐Magdalena, P., Lluesma, M., Ñeco, P., González, A., Marroquí, L., García‐Arévalo, M., Nadal, Á., & Quesada, I. (2015) · Scientific Reports · doi:10.1038/srep11622 · Cited by 36
A central role for hypoxia-inducible factor (HIF)-2α in hepatic glucose homeostasis
Ramakrishnan, S. K., & Shah, Y. M. (2017) · Nutrition and Healthy Aging · doi:10.3233/nha-170022 · Cited by 37
Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34
Han, S., Akiyama, T. E., Previs, S. F., Herath, K. B., Roddy, T. P., Jensen, K. K., Guan, H.-P., Murphy, B. A., McNamara, L. A., Shen, X., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035592 · Cited by 34
Oxyntomodulin increases intrinsic heart rate through the glucagon receptor
Mukharji, A., Drucker, D. J., Charron, M. J., & Swoap, S. J. (2013) · Physiological Reports · doi:10.1002/phy2.112 · Cited by 34
Self-citationHypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade
Mani, B. K., Uchida, A., Lee, Y., Osborne-Lawrence, S. L., Charron, M. J., Unger, R. H., Berglund, E. D., & Zigman, J. M. (2017) · Diabetes · doi:10.2337/db16-1303 · Cited by 34
Self-citationNeumann, U. H., Ho, J. S. S., Chen, S., Tam, Y. Y. C., Cullis, P. R., & Kieffer, T. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.012 · Cited by 33
Pettus, J., D’Alessio, D. A., Frías, J. P., Vajda, E. G., Pipkin, J. D., Rosenstock, J., Williamson, G., Zangmeister, M. A., Zhi, L., & Marschke, K. B. (2019) · Diabetes Care · doi:10.2337/dc19-1328 · Cited by 32
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis
Wendt, A., & Eliasson, L. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102199 · Cited by 35
Fukami, A., Seino, Y., Ozaki, N., Yamamoto, M., Sugiyama, C., Sakamoto-Miura, E., Himeno, T., Takagishi, Y., Tsunekawa, S., Ali, S., et al. (2012) · Diabetes · doi:10.2337/db12-0294 · Cited by 30
Metabolic impact of glucagon deficiency
Hayashi, Y. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01456.x · Cited by 31
Metadata
- Authors
- Conarello, S. L., Jiang, G., Mu, J., Li, Z., Woods, J., Zycband, E., Ronan, J., Liu, F., Roy, R. S., Zhu, L., Charron, M. J., & Zhang, B. B.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Zhang, B. B.
- Venue
- Diabetologia
- Published
- 2006-11-28
- Volume
- 50
- Issue
- 1
- Pages
- 142-150
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1988784323
- Cited by
- 224
- References
- 38
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 12 · 2023: 7 · 2022: 16 · 2021: 15 · 2020: 10 · 2019: 17 · 2018: 17 · 2017: 10 · 2016: 16 · 2015: 17 · 2014: 17 · 2013: 9 · 2012: 14
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glucagon receptor, glucose homeostasis, diet-induced obesity, high-fat diet, beta cell destruction, hyperglycemia, insulin/glucagon ratio, glucagon-like peptide-1, gastric emptying, hepatic steatosis, hyperinsulinemia, leptin, type 2 diabetes
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Dietary Fats, Disease Models, Animal, Glucose, Homeostasis, Hyperglycemia, Male, Mice, Inbred C57BL, Obesity, Streptozocin, Apoptosis, Gene Deletion, Receptors, Glucagon, Mice, Knockout, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
